Epithelial disruption: a new paradigm enabling human airway stem cell transplantation
Abstract Background Airway disease is a primary cause of morbidity and early mortality for patients with cystic fibrosis (CF). Cell transplantation therapy has proven successful for treating immune disorders and may have the potential to correct the airway disease phenotype associated with CF. Since...
Main Authors: | Nigel Farrow, Patricia Cmielewski, Martin Donnelley, Nathan Rout-Pitt, Yuben Moodley, Ivan Bertoncello, David Parsons |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-018-0911-4 |
Similar Items
-
Epithelial mesenchymal transition (EMT): a universal process in lung diseases with implications for cystic fibrosis pathophysiology
by: Nathan Rout-Pitt, et al.
Published: (2018-07-01) -
Three Decades Single Center Experience of Airway Complications After Lung Transplantation
by: R. van Pel, et al.
Published: (2023-10-01) -
Utility and safety of airway stenting in airway stenosis after lung transplant: A systematic review
by: Zilin Wang, et al.
Published: (2023-03-01) -
Airway Telomere Length in Lung Transplant Recipients
by: John A. Mackintosh, et al.
Published: (2021-04-01) -
Airway Management in a Patient with Palato-Maxillo-Orbital Tract as a Sequel of Rhino-Cerbral Mucormycosis Undergoing Kidney Transplantation
by: Mahtab Poor Zamany Nejat Kermany, et al.
Published: (2016-06-01)